Avalyn Pharma Inc. (AVLN) on GreekSoup https://greeksoup.ai/stocks/us/avln/ Every dated entry in the public record on Avalyn Pharma Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 Avalyn Pharma Inc.: short interest 2,354,271 shares at the 15 October 2026 settlement, 6.63 days to coverhttps://greeksoup.ai/stocks/us/avln/short-interest/us:AVLN:short-interest:2026-10-15:ad65a0a242Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc.: short interest 2,516,254 shares at the 30 September 2026 settlement, 8.52 days to coverhttps://greeksoup.ai/stocks/us/avln/short-interest/us:AVLN:short-interest:2026-09-30:28827f16b1Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/avln/filings/us:AVLN:filing:2026-09-16:c93196622cWed, 16 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc.: short interest 2,093,252 shares at the 15 September 2026 settlement, 9.56 days to coverhttps://greeksoup.ai/stocks/us/avln/short-interest/us:AVLN:short-interest:2026-09-15:ad5038f10aTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc.: short interest 1,930,246 shares at the 31 August 2026 settlement, 11.34 days to coverhttps://greeksoup.ai/stocks/us/avln/short-interest/us:AVLN:short-interest:2026-08-31:f5baa27e20Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc.: Schedule 13G filed by Novo Holdings A/S, 8.8% of the classhttps://greeksoup.ai/stocks/us/avln/holders/us:AVLN:schedule-13:2026-08-14:79ea1bc351Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc.: short interest 2,072,596 shares at the 14 August 2026 settlement, 10.93 days to coverhttps://greeksoup.ai/stocks/us/avln/short-interest/us:AVLN:short-interest:2026-08-14:2c726850d1Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc. Q2 FY2025 results: revenue $2 million, net income -$20 millionhttps://greeksoup.ai/stocks/us/avln/results/fy2025-q2/us:AVLN:result:2026-08-12:067578769aWed, 12 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc. Q2 FY2026 results: revenue $3 million, net income -$29 millionhttps://greeksoup.ai/stocks/us/avln/results/fy2026-q2/us:AVLN:result:2026-08-12:a44d493ed9Wed, 12 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/avln/filings/us:AVLN:filing:2026-08-12:8a8cd7613dWed, 12 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/avln/filings/us:AVLN:filing:2026-08-12:f132b27627Wed, 12 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc.: Schedule 13G filed by Norwest Venture Partners XV, LP, 5.1% of the classhttps://greeksoup.ai/stocks/us/avln/holders/us:AVLN:schedule-13:2026-08-11:f0c23da853Tue, 11 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Avalyn Pharma Inc.: Schedule 13G/A filed by FMR LLC, 13.2% of the classhttps://greeksoup.ai/stocks/us/avln/holders/us:AVLN:schedule-13:2026-08-06:4c48e51ae9Thu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]>